Case Number

Age (in Years)

Gender

Diagnosis

WBC Profile

RBC Profile

Platelets Profile

1

43

Male

Acute Promyelocytic Leukemia

WBC: 0.96 × 10⁹/L

N (21.94%), L (66.74%)

RBC: 2.43 × 10¹²/L

Hb: 79 g/L

MCV: 91.81 fl

RET%: 0.04%

29 × 10⁹/L

2

80

Male

Megaloblastic Anemia

WBC: 2.74 × 10⁹/L

N (20.42%), L (74.51%)

RBC: 1.3 × 10¹²/L

Hb: 57 g/L

MCV: 123.8 fl

RET%: 0.77%

13 × 10⁹/L

3

61

Female

Hypersplenism

WBC: 2.32 × 10⁹/L

N (55.6%), L (34.9%)

RBC: 3.32 × 10¹²/L

Hb: 96 g/L

MCV: 93.1 fl

RET%: 3.41%

95 × 10⁹/L

4

60

Male

Megaloblastic Anemia

WBC: 3.04 × 10⁹/L

N (25.6%), L (60.9%)

RBC: 1.67 × 10¹²/L

Hb: 72 g/L

MCV: 131.7 fl

RET%: 0.68%

47 × 10⁹/L

5

72

Male

Acute Myeloid Leukemia

WBC: 2.85 × 10⁹/L

N (5.7%), L (77.54%)

RBC: 2.17 × 10¹²/L

Hb: 82 g/L

MCV: 114.7 fl

RET%: 0.68%

79 × 10⁹/L

6

69

Female

Myelodysplastic

Syndrome

WBC: 1.37 × 10⁹/L

N (51.1%), L (32.1%)

RBC: 2.75 × 10¹²/L

Hb: 96 g/L

MCV: 106.9 fl

RET%: 2.49%

20 × 10⁹/L

7

34

Female

Aplastic Anemia

WBC: 1.51 × 10⁹/L

N (45.7%), L (43.7%)

RBC: 2.18 × 10¹²/L

Hb: 73 g/L

MCV: 96.8 fl

RET%: 1%

6 × 10⁹/L

8

59

Female

HIV/AIDS

WBC: 1.27 × 10⁹/L

N (55.9%), L(26%)

RBC: 2.64 × 10¹²/L

Hb: 75 g/L

MCV: 85.2 fl

RET%: 1.2%

33 × 10⁹/L

9

59

Female

Megaloblastic Anemia

WBC: 3.55 × 10⁹/L

N (55.54%), L (37.54%)

RBC: 1.7 × 10¹²/L

Hb: 73 g/L

MCV: 130.6 fl

RET%: 0.85%

46 × 10⁹/L

10

62

Female

Myelodyspalstic Syndrome

WBC: 1.81 × 10⁹/L

N (22.64%), L (73.54%)

RBC: 2.02 × 10¹²/L

Hb: 68 g/L

MCV: 105.9 fl

RET%: 0.62%

85 × 10⁹/L

11

57

Female

Acute P romyelocytic Leukemia

WBC: 1.11 × 10⁹/L

N (5.42%), L (91.91%)

RBC: 2.12 × 10¹²/L

Hb: 63 g/L

MCV: 93.9 fl

RET%: 1.78%

78 × 10⁹/L

12

58

Male

Aplastic Anemia

WBC: 0.63 ×10⁹/L

N (23.84%), L (74.64%)

RBC: 1.74 × 10¹²/L

Hb: 53 g/L

MCV: 92 fl

RET%: 1.17%

20 × 10⁹/L

13

46

Male

Megaloblastic Anemia

WBC: 3.51 × 10⁹/L

N (50%), L (40%)

RBC: 2.12 × 10¹²/L

Hb: 81 g/L

MCV: 109.9 fl

RET%: 5.43

113 × 10⁹/L